rs2917726

Positions:

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_152743.4(BRAT1):​c.1923G>A​(p.Ala641=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0586 in 1,597,516 control chromosomes in the GnomAD database, including 4,204 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.048 ( 349 hom., cov: 34)
Exomes 𝑓: 0.060 ( 3855 hom. )

Consequence

BRAT1
NM_152743.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.460
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 7-2538612-C-T is Benign according to our data. Variant chr7-2538612-C-T is described in ClinVar as [Benign]. Clinvar id is 585488.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.46 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.237 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BRAT1NM_152743.4 linkuse as main transcriptc.1923G>A p.Ala641= synonymous_variant 14/14 ENST00000340611.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BRAT1ENST00000340611.9 linkuse as main transcriptc.1923G>A p.Ala641= synonymous_variant 14/141 NM_152743.4 P1Q6PJG6-1

Frequencies

GnomAD3 genomes
AF:
0.0484
AC:
7365
AN:
152154
Hom.:
348
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0721
Gnomad ASJ
AF:
0.0657
Gnomad EAS
AF:
0.247
Gnomad SAS
AF:
0.0624
Gnomad FIN
AF:
0.0354
Gnomad MID
AF:
0.0701
Gnomad NFE
AF:
0.0505
Gnomad OTH
AF:
0.0497
GnomAD3 exomes
AF:
0.0680
AC:
15287
AN:
224900
Hom.:
893
AF XY:
0.0660
AC XY:
8266
AN XY:
125274
show subpopulations
Gnomad AFR exome
AF:
0.0104
Gnomad AMR exome
AF:
0.0783
Gnomad ASJ exome
AF:
0.0721
Gnomad EAS exome
AF:
0.248
Gnomad SAS exome
AF:
0.0557
Gnomad FIN exome
AF:
0.0307
Gnomad NFE exome
AF:
0.0499
Gnomad OTH exome
AF:
0.0546
GnomAD4 exome
AF:
0.0596
AC:
86198
AN:
1445244
Hom.:
3855
Cov.:
83
AF XY:
0.0593
AC XY:
42657
AN XY:
719450
show subpopulations
Gnomad4 AFR exome
AF:
0.00936
Gnomad4 AMR exome
AF:
0.0782
Gnomad4 ASJ exome
AF:
0.0726
Gnomad4 EAS exome
AF:
0.276
Gnomad4 SAS exome
AF:
0.0573
Gnomad4 FIN exome
AF:
0.0310
Gnomad4 NFE exome
AF:
0.0533
Gnomad4 OTH exome
AF:
0.0641
GnomAD4 genome
AF:
0.0484
AC:
7374
AN:
152272
Hom.:
349
Cov.:
34
AF XY:
0.0510
AC XY:
3799
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.0124
Gnomad4 AMR
AF:
0.0724
Gnomad4 ASJ
AF:
0.0657
Gnomad4 EAS
AF:
0.248
Gnomad4 SAS
AF:
0.0626
Gnomad4 FIN
AF:
0.0354
Gnomad4 NFE
AF:
0.0505
Gnomad4 OTH
AF:
0.0501
Alfa
AF:
0.0500
Hom.:
44
Bravo
AF:
0.0504
Asia WGS
AF:
0.146
AC:
506
AN:
3478
EpiCase
AF:
0.0508
EpiControl
AF:
0.0489

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 20, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 15, 2018- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 21. Only high quality variants are reported. -
Neonatal-onset encephalopathy with rigidity and seizures Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
5.0
DANN
Benign
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2917726; hg19: chr7-2578246; COSMIC: COSV61394030; COSMIC: COSV61394030; API